People · Operator

Jonathan C. Lieber

Named in public records as an officer, director or promoter · active 2023–2023 · Biotechnology

1
Companies
1
Filings
$34.6M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Salarius Pharmaceuticals, Inc.BiotechnologySeries B$34.6M$57.8M2023
Operator network

Jonathan C. Lieber at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Peter Barton Hutt · 14 companies · 1 sharedPeter Barton HuttChristoph Westphal · 8 companies · 1 sharedChristoph WestphalDavid J. Arthur · 3 companies · 1 sharedDavid J. ArthurMARK J. ROSENBLUM · 3 companies · 1 sharedMARK J. ROSENBLUMJonathan J. Lieber · 2 companies · 1 sharedJonathan J. LieberArnold C. Hanish · 1 companies · 1 sharedArnold C. HanishBruce J. McCreedy · 1 companies · 1 sharedBruce J. McCreedyPaul C. Lammers · 1 companies · 1 sharedPaul C. LammersStephen Barton Kraus · 1 companies · 1 sharedStephen Barton Kr…Tess Burleson · 1 companies · 1 sharedTess BurlesonTess J. Burleson · 1 companies · 1 sharedTess J. BurlesonTess K. Burleson · 1 companies · 1 sharedTess K. BurlesonWilliam J. McVicar · 1 companies · 1 sharedWilliam J. McVicarWilliam K. McVicar · 1 companies · 1 sharedWilliam K. McVicarSalarius Pharmaceuticals, Inc. · $34.6M raisedSalarius Pharmaceutic…Jonathan C. LieberJL
Jonathan C. Lieber Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Jonathan C. Lieber on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Peter Barton Hutt114
Christoph Westphal18
MARK J. ROSENBLUM13
David J. Arthur13
Jonathan J. Lieber12
Paul C. Lammers11
Tess J. Burleson11
William K. McVicar11
Tess Burleson11
Tess K. Burleson11
Stephen Barton Kraus11
Arnold C. Hanish11
William J. McVicar11
Bruce J. McCreedy11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.